- Conditions
- NF1, Congenital Pseudarthrosis of Tibia
- Interventions
- INFUSE Bone Graft (BMP-2), Control Group
- Device · Procedure
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 2 Years to 18 Years
- Enrollment
- 5 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2020
- U.S. locations
- 15
- States / cities
- Birmingham, Alabama • Los Angeles, California • Washington D.C., District of Columbia + 10 more
Source: ClinicalTrials.gov public record
Updated Oct 26, 2021 · Synced May 22, 2026, 5:25 AM EDT